Table 3 Summary of information relating to the adverse effects in the treatment arms
Adverse effects (AE) | Number (%) | ||
|---|---|---|---|
Organ systems | Type | CinnoRA® | Humira® |
Patients with at least one AE, total* | 24 (35.29) | 30 (44.12) | |
Dermatologic | Hives | 2 (2.94) | 5 (7.35) |
Swelling | |||
Rash | |||
Local | Inject site react., erythema | 6 (8.82) | 12 (17.65) |
Inject site react., itching | |||
Inject site react., hemorrhage | |||
Inject site react., swelling | |||
Inject site react., pain | |||
Respiratory | Sinusitis | 6 (8.82) | 14 (20.59) |
Flu-like syndrome | |||
Difficulty breathing | |||
Respiratory infection | |||
Gastrointestinal | Nausea | 5 (7.35) | 2 (2.94) |
Abdominal pain | |||
Central nervous system | Headache | 4 (5.88) | 4 (5.88) |
Renal | Urinary tract infection | 1 (1.47) | 1 (1.47) |
Neuromuscular | Back pain | 1 (1.47) | 2 (2.94) |
Other | Other | 11 (16.18) | 6 (8.82) |